Norio Ohmagari

InstitutionNational Center for Global Health and Medicine
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 83 Covid-19 publications, with a maximum of 11 publications in April 2021
    All Publications
    Bar chart showing 244 publications over 18 distinct years, with a maximum of 43 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Asai Y, Tsuzuki S, Suzuki S, Toyoda A, Suzuki K, Endo M, Fujii N, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Izumi K, Terada-Hirashima J, Mikami A, Sugiura W, Ohmagari N. Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan. Clin Infect Dis. 2021 12 06; 73(11):e3677-e3689. PMID: 32986793.
      Citations: 27     Fields:    Translation:Humans
    2. Rodríguez-Baño J, Rossolini GM, Schultsz C, Tacconelli E, Murthy S, Ohmagari N, Holmes A, Bachmann T, Goossens H, Canton R, Roberts AP, Henriques-Normark B, Clancy CJ, Huttner B, Fagerstedt P, Lahiri S, Kaushic C, Hoffman SJ, Warren M, Zoubiane G, Essack S, Laxminarayan R, Plant L. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg. 2021 10 01; 115(10):1122-1129. PMID: 33772597.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    3. Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, Moriya A, Maeda K, Kimura M, Ohmagari N. Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients. J Infect Chemother. 2021 Nov; 27(11):1669-1673. PMID: 34454833.
      Citations:    Fields:    Translation:Humans
    4. Togano T, Uemura Y, Asai Y, Hayakawa K, Matsunaga N, Terada M, Ohtsu H, Suzuki S, Toyoda A, Hara H, Sato R, Ishikane M, Kinoshita-Iwamoto N, Hangaishi A, Ohmagari N. The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Oct; 27(10):1498-1503. PMID: 34340930.
      Citations: 1     Fields:    Translation:Humans
    5. Okuhama A, Ishikane M, Hotta M, Sato L, Akiyama Y, Morioka S, Suzuki S, Tajima T, Yamamoto M, Teruya K, Izumi S, Ohmagari N. Clinical and radiological findings of silent hypoxia among COVID-19 patients. J Infect Chemother. 2021 Oct; 27(10):1536-1538. PMID: 34294527.
      Citations:    Fields:    Translation:Humans
    6. Citations: 12     Fields:    Translation:HumansAnimals
    7. Ide S, Kutsuna S, Yamada G, Hashimoto K, Abe M, Nagi M, Ujiie M, Hayakawa K, Ohmagari N. Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report. J Infect Chemother. 2021 Nov; 27(11):1658-1661. PMID: 34175216.
      Citations:    Fields:    Translation:HumansAnimals
    8. Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya A, Maeda K, Yagi S, Kimura M, Ohmagari N. Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72]. Int J Infect Dis. 2021 Aug; 109:323. PMID: 34172380.
      Citations:    Fields:    
    9. Terada M, Ohtsu H, Saito S, Hayakawa K, Tsuzuki S, Asai Y, Matsunaga N, Kutsuna S, Sugiura W, Ohmagari N. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021 06 15; 11(6):e047007. PMID: 34130961.
      Citations: 3     Fields:    Translation:Humans
    10. Citations: 1     Fields:    Translation:HumansPHPublic Health
    11. Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J, Yoshimura K, Ohmagari N. A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea. Jpn J Infect Dis. 2022 Jan 24; 75(1):36-40. PMID: 34053956.
      Citations:    Fields:    
    12. Yamamoto S, Tanaka A, Oshiro Y, Ishii M, Ishiwari H, Konishi M, Matsuda K, Ozeki M, Miyo K, Maeda K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan. J Infect. 2021 08; 83(2):237-279. PMID: 34044036.
      Citations:    Fields:    Translation:HumansPHPublic Health
    13. Ide S, Hayama H, Asai Y, Terada M, Nomoto H, Kutsuna S, Ohmagari N, Hiroi Y. Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019. Circ J. 2021 05 25; 85(6):944-947. PMID: 33994409.
      Citations:    Fields:    Translation:HumansCells
    14. Yamamoto K, Nagashima M, Yoshida I, Sadamasu K, Kurokawa M, Nagashima M, Kinoshita N, Maeda K, Takasaki J, Teruya K, Ohmagari N. Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result? J Infect Chemother. 2021 Aug; 27(8):1273-1275. PMID: 34023222.
      Citations:    Fields:    Translation:Humans
    15. Suzuki T, Kutsuna S, Saito S, Kawashima A, Okuhama A, Kanda K, Sato L, Inada M, Akiyama Y, Ide S, Nakamura K, Nakamoto T, Yamamoto K, Ishikane M, Kinoshita N, Morioka S, Hayakawa K, Ohmagari N. Clinical course of alopecia after COVID-19. Int J Infect Dis. 2021 06; 107:255-256. PMID: 33962081.
      Citations: 1     Fields:    
    16. Ogawa T, Uemura T, Matsuda W, Sato M, Ishizuka K, Fukaya T, Kinoshita N, Nakamoto T, Ohmagari N, Katano H, Suzuki T, Hosaka S. SARS-CoV-2 Leakage From the Gas Outlet Port During Extracorporeal Membrane Oxygenation for COVID-19. ASAIO J. 2021 05 01; 67(5):511-516. PMID: 33492852.
      Citations: 1     Fields:    Translation:Humans
    17. Saito S, Hayakawa K, Mikami A, Izumi S, Funazaki H, Ashida S, Sugiura W, Sugiyama H, Kokudo N, Ohmagari N. Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan. Glob Health Med. 2021 Apr 30; 3(2):62-66. PMID: 33937567.
      Citations: 1     
    18. Yamamoto S, Tanaka A, Kobayashi S, Oshiro Y, Ozeki M, Maeda K, Matsuda K, Miyo K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan. Glob Health Med. 2021 Apr 30; 3(2):90-94. PMID: 33937571.
      Citations:    
    19. Hayama H, Ide S, Moroi M, Kitami Y, Bekki N, Kubota S, Uemura Y, Hara H, Kutsuna S, Ohmagari N, Hiroi Y. Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019. Glob Health Med. 2021 Apr 30; 3(2):95-101. PMID: 33937572.
      Citations: 1     
    20. Fujita M, Umeda T, Fujita N, Nishioka T, Iwamoto A, Ohmagari N, Ishikane M, Akashi H, Kokudo N. Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19. Glob Health Med. 2021 Apr 30; 3(2):115-118. PMID: 33937576.
      Citations:    
    21. Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. J Infect Chemother. 2021 Jul; 27(7):1063-1067. PMID: 33962861.
      Citations: 1     Fields:    Translation:Humans
    22. Khor SS, Omae Y, Nishida N, Sugiyama M, Kinoshita N, Suzuki T, Suzuki M, Suzuki S, Izumi S, Hojo M, Ohmagari N, Mizokami M, Tokunaga K. HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure. Front Immunol. 2021; 12:658570. PMID: 33968060.
      Citations: 4     Fields:    Translation:Humans
    23. Yamada G, Hayakawa K, Asai Y, Matsunaga N, Ohtsu H, Hojo M, Hashimoto M, Kobayashi K, Sasaki R, Okamoto T, Yanagawa Y, Katagiri D, Terada M, Suzuki M, Sato L, Miyazato Y, Ishikane M, Morioka S, Saito S, Ohmagari N. External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul; 27(7):1043-1050. PMID: 33865699.
      Citations:    Fields:    Translation:Humans
    24. Fukunaga A, Inoue Y, Yamamoto S, Miki T, Nanri A, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T. Association Between Adherence to Healthy Lifestyles and Depressive Symptoms Among Japanese Hospital Workers During the COVID-19 Pandemic. Asia Pac J Public Health. 2021 11; 33(8):847-853. PMID: 33829896.
      Citations:    Fields:    Translation:HumansPHPublic Health
    25. Nangaku M, Kadowaki T, Yotsuyanagi H, Ohmagari N, Egi M, Sasaki J, Sakamoto T, Hasegawa Y, Ogura T, Chiba S, Node K, Suzuki R, Yamaguchi Y, Murashima A, Ikeda N, Morishita E, Yuzawa K, Moriuchi H, Hayakawa S, Nishi D, Irisawa A, Miyamoto T, Suzuki H, Sone H, Fujino Y. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. JMA J. 2021 Apr 15; 4(2):148-162. PMID: 33997449.
      Citations:    
    26. Yamamoto K, Ohmagari N. Microbiological Testing for Coronavirus Disease 2019. JMA J. 2021 Apr 15; 4(2):67-75. PMID: 33997438.
      Citations: 1     
    27. Inoue Y, Yamamoto S, Fukunaga A, Hoang DV, Miki T, Islam Z, Miyo K, Ishii M, Ishiwari H, Konishi M, Ohmagari N, Mizoue T. Association between engagement in COVID-19-related work and depressive symptoms among hospital workers in a designated COVID-19 hospital in Japan: a cross-sectional study. BMJ Open. 2021 04 01; 11(4):e049996. PMID: 33795314.
      Citations: 1     Fields:    Translation:Humans
    28. Miyazato Y, Ishikane M, Inada M, Ohmagari N. Acute portal vein thrombosis with COVID-19 and cirrhosis. IDCases. 2021; 24:e01094. PMID: 33816118.
      Citations: 1     
    29. Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H. Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Sci Rep. 2021 03 10; 11(1):5563. PMID: 33692457.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    30. Noda K, Matsuda K, Yagishita S, Maeda K, Akiyama Y, Terada-Hirashima J, Matsushita H, Iwata S, Yamashita K, Atarashi Y, Watanabe S, Ide N, Yoshida T, Ohmagari N, Mitsuya H, Hamada A. A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies. Sci Rep. 2021 03 04; 11(1):5198. PMID: 33664294.
      Citations: 4     Fields:    Translation:Humans
    31. Rodríguez-Baño J, Rossolini GM, Schultsz C, Tacconelli E, Murthy S, Ohmagari N, Holmes A, Bachmann T, Goossens H, Canton R, Roberts AP, Henriques-Normark B, Clancy CJ, Huttner B, Fagerstedt P, Lahiri S, Kaushic C, Hoffman SJ, Warren M, Zoubiane G, Essack S, Laxminarayan R, Plant L. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J Glob Antimicrob Resist. 2021 06; 25:5-7. PMID: 33662647.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    32. Ide S, Hayakawa K, Yamamoto K, Tsuzuki S, Tanuma J, Ohara K, Yamada G, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Nakamura K, Nomoto H, Nakamoto T, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Tanaka K, Ohmagari N. Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):481-486. PMID: 33642432.
      Citations:    Fields:    Translation:HumansPHPublic Health
    33. Miki T, Yamamoto S, Inoue Y, Fukunaga A, Islam Z, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T. Association between living with others and depressive symptoms in Japanese hospital workers during the COVID-19 pandemic. Psychiatry Clin Neurosci. 2021 04; 75(4):148-149. PMID: 33511693.
      Citations: 1     Fields:    Translation:Humans
    34. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T, Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada K, Fujita R, Saito H, Okinaka K, Griffith M, Parry AE, Barnetson B, Leonard J, Wakita T. Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship. J Infect Dis. 2021 02 13; 223(3):540. PMID: 32905593.
      Citations:    Fields:    
    35. Fujino T, Nomoto H, Kutsuna S, Ujiie M, Suzuki T, Sato R, Fujimoto T, Kuroda M, Wakita T, Ohmagari N. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan. Emerg Infect Dis. 2021 04; 27(4). PMID: 33567247.
      Citations: 42     Fields:    Translation:HumansPHPublic Health
    36. Tanaka A, Yamamoto S, Miyo K, Mizoue T, Maeda K, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan. J Infect. 2021 04; 82(4):e1-e3. PMID: 33524423.
      Citations: 8     Fields:    Translation:Humans
    37. Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Kenji M, Takasaki J, Hojo M, Ishizaka Y, Ohmagari N. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother. 2021 Jun; 27(6):808-813. PMID: 33531292.
      Citations: 3     Fields:    Translation:Humans
    38. Sato L, Kinoshita N, Nakamoto T, Ohmagari N. Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia. Intern Med. 2021 Mar 01; 60(5):803-805. PMID: 33456035.
      Citations: 5     Fields:    Translation:Humans
    39. Nomoto H, Kutsuna S, Okuma K, Kuramitsu M, Tezuka K, Ikebe E, Saito S, Kinoshita N, Terada M, Endo M, Suzuki T, Miyazato Y, Nakamoto T, Inada M, Hamaguchi I, Ohmagari N. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J Infect Chemother. 2021 Apr; 27(4):653-655. PMID: 33487533.
      Citations: 1     Fields:    Translation:Humans
    40. Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya A, Maeda K, Yagi S, Kimura M, Ohmagari N. Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission. Int J Infect Dis. 2021 Mar; 104:65-72. PMID: 33401037.
      Citations: 3     Fields:    Translation:Humans
    41. Osanai Y, Kinoshita N, Hayakawa K, Tanaka K, Hamano T, Kutsuna S, Ujiie M, Morioka S, Yamamoto K, Isikane M, Saito S, Sugiura Y, Ohmagari N. Telephone consults at the Infectious Disease Outpatient Clinic during the early period of the COVID-19 epidemic. Glob Health Med. 2020 Dec 31; 2(6):392-394. PMID: 33409420.
      Citations:    
    42. Yashiro S, Ueta T, Kutsuna S, Okamoto T, Nagahara M, Ohmagari N. Using flowchart for ophthalmic consultations in hospitalized patients with COVID-19. Glob Health Med. 2020 Dec 31; 2(6):395-397. PMID: 33409421.
      Citations: 1     
    43. Terada-Hirashima J, Suzuki M, Uemura Y, Hojo M, Mikami A, Sugiura W, Ohmagari N, Sugiyama H. Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial. JMIR Res Protoc. 2020 Dec 31; 9(12):e23830. PMID: 33206053.
      Citations: 3     
    44. Kamata K, Jindai K, Ide K, Funaki T, Saito H, Takeshita N, Ohmagari N, Hinoshita E, Asanuma K. The Flight Evacuation Mission for COVID-19 from Wuhan, China to Tokyo, Japan from January 28 to February 17, 2020. Jpn J Infect Dis. 2021 Jul 21; 74(4):373-376. PMID: 33390435.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    45. Asai Y, Tsuzuki S, Kutsuna S, Hayakawa K, Ohmagari N. Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study. J Infect Chemother. 2021 Mar; 27(3):515-520. PMID: 33380364.
      Citations:    Fields:    Translation:HumansPHPublic Health
    46. Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y, Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama H. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321. PMID: 33325084.
      Citations: 7     Fields:    Translation:Humans
    47. Hayama H, Ishikane M, Sato R, Kanda K, Kinoshita N, Izumi S, Ohmagari N, Hiroi Y. Association of plain computed tomography-determined pulmonary artery-to-aorta ratio with clinical severity of coronavirus disease 2019. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020969492. PMID: 33282198.
      Citations:    
    48. Akiyama Y, Morioka S, Wakimoto Y, Kawashima A, Kanda K, Okuhama A, Suzuki T, Miyazato Y, Nomoto H, Ide S, Nakamoto T, Nakamura K, Ota M, Moriyama Y, Takaya S, Yamada K, Taguchi M, Sugito E, Izuka S, Ishiguro K, Kobayashi T, Miyake W, Kubota S, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hayakawa K, Saito S, Ohmagari N. Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan. Intern Med. 2020 Dec 15; 59(24):3131-3133. PMID: 33132334.
      Citations:    Fields:    Translation:HumansPHPublic Health
    49. Ide S, Morioka S, Inada M, Ohmagari N. Beau's Lines and Leukonychia in a COVID-19 Patient. Intern Med. 2020 12 15; 59(24):3259. PMID: 33132338.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    50. Saito S, Asai Y, Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Tsuzuki S, Ohmagari N. First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics. J Infect. 2021 04; 82(4):84-123. PMID: 33152376.
      Citations: 41     Fields:    Translation:Humans
    51. Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K, Terada M, Suzuki M, Kutsuna S, Saito S, Hayakawa K, Ohmagari N. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa507. PMID: 33230486.
      Citations: 15     
    52. Nakamoto T, Ishikane M, Sasaki R, Ohmagari N. Periungual desquamation in a Japanese Adult recovering from severe COVID-19. Int J Infect Dis. 2021 Jan; 102:37-39. PMID: 33075533.
      Citations:    Fields:    Translation:Humans
    53. Takaya S, Tsuzuki S, Hayakawa K, Kawashima A, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Nomoto H, Nakamoto T, Hikida S, Tanuma J, Ohara K, Ito T, Baba T, Yamamoto K, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N. Nightlife clusters of coronavirus disease in Tokyo between March and April 2020. Epidemiol Infect. 2020 10 13; 148:e250. PMID: 33046159.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    54. Nakamura K, Morioka S, Kutsuna S, Iida S, Suzuki T, Kinoshita N, Suzuki T, Sugiki Y, Okuhama A, Kanda K, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Moriyama Y, Ota M, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Miyazato Y, Hayakawa K, Saito S, Ohmagari N. Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infect Prev Pract. 2020 Dec; 2(4):100098. PMID: 34316568.
      Citations: 1     
    55. Citations: 1655     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    56. Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145. PMID: 32941953.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    57. Suzuki T, Hayakawa K, Ainai A, Iwata-Yoshikawa N, Sano K, Nagata N, Suzuki T, Wakimoto Y, Akiyama Y, Miyazato Y, Nakamura K, Ide S, Nomoto H, Nakamoto T, Ota M, Moriyama Y, Sugiki Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122. PMID: 32988731.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    58. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T, Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada K, Fujita R, Saito H, Okinaka K, Griffith M, Parry AE, Barnetson B, Leonard J, Wakita T. Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship. J Infect Dis. 2020 09 01; 222(7):1098-1102. PMID: 32691828.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    59. Yamamoto K, Saito S, Hayakawa K, Hashimoto M, Takasaki J, Ohmagari N. When Clinicians Should Repeat RT-PCR for SARS-CoV-2: Repeat PCR Testing in Patients with Pulmonary CT Findings Suggestive of COVID-19. Jpn J Infect Dis. 2021 Mar 24; 74(2):161-165. PMID: 32863359.
      Citations: 1     Fields:    Translation:Humans
    60. Kusaba Y, Izumi S, Takasaki J, Suzuki M, Katagiri D, Katsuno T, Matsumoto S, Sakamoto K, Hashimoto M, Ohmagari N, Katano H, Suzuki T, Hojo M, Sugiyama H. Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion. Intern Med. 2020 Oct 01; 59(19):2405-2408. PMID: 32863364.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    61. Ujiie M, Ohmagari N, Inoue H. Testing for COVID-19 at travel clinics in Japan. J Travel Med. 2020 Aug 20; 27(5). PMID: 32597471.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    62. Oda R, Inagaki T, Ishikane M, Hotta M, Shimomura A, Sato M, Nakamoto T, Akiyama Y, Yamamoto K, Minamimoto R, Kaneko H, Ohmagari N. Case of adult large vessel vasculitis after SARS-CoV-2 infection. Ann Rheum Dis. 2020 Aug 11. PMID: 32788398.
      Citations: 9     Fields:    
    63. Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Okuhama A, Kanda K, Wakimoto Y, Morioka S, Saito S, Yamamoto K, Ujiie M, Hayakawa K, Kustuna S, Yanagawa Y, Terada J, Takasaki J, Izumi S, Hojo M, Hinoshita F, Sugiyama M, Noiri E, Mizokami M, Ohmagari N, Sugiyama H. Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170. PMID: 32766565.
      Citations: 4     
    64. Okuhama A, Ishikane M, Katagiri D, Kanda K, Nakamoto T, Kinoshita N, Nunose N, Fukaya T, Kondo I, Katano H, Suzuki T, Ohmagari N, Hinoshita F. Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan. Emerg Infect Dis. 2020 Nov; 26(11):2758-2761. PMID: 32730734.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    65. Morioka S, Nakamura K, Iida S, Kutsuna S, Kinoshita N, Suzuki T, Suzuki T, Yamamoto K, Hayakawa K, Saito S, Ohmagari N. Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study. Infect Prev Pract. 2020 Sep; 2(3):100079. PMID: 34316564.
      Citations:    
    66. Nakamoto T, Kutsuna S, Yanagawa Y, Kanda K, Okuhama A, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Yamamoto K, Ohmagari N. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan. J Med Virol. 2021 01; 93(1):40-42. PMID: 32492188.
      Citations: 5     Fields:    Translation:Humans
    67. Nakamura K, Ide S, Saito S, Kinoshita N, Kutsuna S, Moriyama Y, Suzuki T, Ota M, Nomoto H, Mizoue T, Hojo M, Takasaki J, Asai Y, Terada M, Akiyama Y, Miyazato Y, Nakamoto T, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Morioka S, Hayakawa K, Sugiyama H, Ohmagari N. COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177. PMID: 33330803.
      Citations: 1     
    68. Sato R, Ishikane M, Kinoshita N, Suzuki T, Nakamoto T, Hayakawa K, Bekki N, Hara H, Ohmagari N. A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan. Glob Health Med. 2020 Jun 30; 2(3):190-192. PMID: 33330806.
      Citations: 2     
    69. Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M, Yamada S, Fan S, Chiba S, Kuroda M, Guan L, Takada K, Armbrust T, Balogh A, Furusawa Y, Okuda M, Ueki H, Yasuhara A, Sakai-Tagawa Y, Lopes TJS, Kiso M, Yamayoshi S, Kinoshita N, Ohmagari N, Hattori SI, Takeda M, Mitsuya H, Krammer F, Suzuki T, Kawaoka Y. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020 07 14; 117(28):16587-16595. PMID: 32571934.
      Citations: 262     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    70. Citations: 4     
    71. Katagiri D, Ishikane M, Ogawa T, Kinoshita N, Katano H, Suzuki T, Fukaya T, Hinoshita F, Ohmagari N. Continuous Renal Replacement Therapy for a Patient with Severe COVID-19. Blood Purif. 2021; 50(1):129-131. PMID: 32526746.
      Citations: 6     Fields:    Translation:Humans
    72. Yamamoto M, Kiso M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Takeda M, Kinoshita N, Ohmagari N, Gohda J, Semba K, Matsuda Z, Kawaguchi Y, Kawaoka Y, Inoue JI. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Viruses. 2020 06 10; 12(6). PMID: 32532094.
      Citations: 65     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    73. Nomoto H, Ishikane M, Katagiri D, Kinoshita N, Nagashima M, Sadamasu K, Yoshimura K, Ohmagari N. Cautious handling of urine from moderate to severe COVID-19 patients. Am J Infect Control. 2020 08; 48(8):969-971. PMID: 32502614.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    74. Ishikane M, Miyazato Y, Kustuna S, Suzuki T, Ide S, Nakamura K, Morioka S, Katano H, Suzuki T, Ohmagari N. A Case of COVID-19 Patient with False-Negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese Traveller Returning from Wuhan, Hubei Province, China, January 2020. Jpn J Infect Dis. 2020 Nov 24; 73(6):462-464. PMID: 32475881.
      Citations:    Fields:    Translation:Humans
    75. Suzuki T, Kutsuna S, Nakamura K, Ide S, Moriyama Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Hayakawa K, Ohmagari N. Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection. J Infect Chemother. 2020 Aug; 26(8):851-853. PMID: 32423700.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    76. Ujiie M, Tsuzuki S, Ohmagari N. Effect of temperature on the infectivity of COVID-19. Int J Infect Dis. 2020 Jun; 95:301-303. PMID: 32360939.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    77. Ito K, Ohmagari N, Mikami A, Sugiura W. Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan. Glob Health Med. 2020 Apr 30; 2(2):96-101. PMID: 33330784.
      Citations: 6     
    78. Hayakawa K, Kutsuna S, Kawamata T, Sugiki Y, Nonaka C, Tanaka K, Shoji M, Nagai M, Tezuka S, Shinya K, Saito H, Harada T, Moriya N, Tsuboi M, Norizuki M, Sugiura Y, Osanai Y, Sugiyama M, Okuhama A, Kanda K, Wakimoto Y, Ujiie M, Morioka S, Yamamoto K, Kinoshita N, Ishikane M, Saito S, Moriyama Y, Ota M, Nakamura K, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Suzuki T, Miyazato Y, Gu Y, Matsunaga N, Tsuzuki S, Fujitomo Y, Kusama Y, Shichino H, Kaneshige M, Yamanaka J, Saito M, Hojo M, Hashimoto M, Izumi S, Takasaki J, Suzuki M, Sakamoto K, Hiroi Y, Emoto S, Tokuhara M, Kobayashi T, Tomiyama K, Nakamura F, Ohmagari N, Sugiyama H. SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111. PMID: 33330786.
      Citations: 5     
    79. Kuwahara K, Hori A, Ohmagari N, Mizoue T. Early cases of COVID-19 in Tokyo and occupational health. Glob Health Med. 2020 Apr 30; 2(2):118-122. PMID: 33330788.
      Citations: 2     
    80. Morioka S, Saito S, Hayakawa K, Takasaki J, Suzuki T, Ide S, Nakamura K, Moriyama Y, Akiyama Y, Miyazato Y, Nomoto H, Nakamoto T, Ota M, Sakamoto K, Katsuno T, Kusaba Y, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hashimoto M, Suzuki M, Izumi S, Katagiri D, Hojo M, Ohmagari N. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 07; 289:113040. PMID: 32387791.
      Citations: 2     Fields:    
    81. Morioka S, Saito S, Hayakawa K, Takasaki J, Suzuki T, Ide S, Nakamura K, Moriyama Y, Akiyama Y, Miyazato Y, Nomoto H, Nakamoto T, Ota M, Sakamoto K, Katsuno T, Kusaba Y, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hashimoto M, Suzuki M, Izumi S, Katagiri D, Hojo M, Ohmagari N. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 Apr 29; 289:113040. PMID: 33242806.
      Citations:    Fields:    
    82. Citations: 1017     Fields:    Translation:HumansCellsPHPublic Health
    83. Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020 03 31; 117(13):7001-7003. PMID: 32165541.
      Citations: 393     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    84. Matsuyama R, Nishiura H, Kutsuna S, Hayakawa K, Ohmagari N. Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis. BMC Public Health. 2016 11 29; 16(1):1203. PMID: 27899100.
      Citations: 57     Fields:    Translation:Humans
    Ohmagari's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (446)
    Explore
    _
    Co-Authors (582)
    Explore
    _
    Similar People (60)
    Explore
    _